Ad hoc: Biofrontera AG: Biofrontera AG successfully places capital increase
(Thomson Reuters ONE) - Biofrontera AG / Capital increase / Ad hoc: Biofrontera AG successfully places capital increase Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------Leverkusen, Germany, September 09, 2009 - Biofrontera AG announcesthat the subscription of shares in the anticipated capital increasewas closed. According to the current assessment the subscription of1.2 million shares at a share price of ? 1.50 is documented. Thesuccessful completion of the capital increase represents anotherrelevant mile-stone in the financial stabilization of the Biofronteragroup.Already earlier in the year Biofrontera restructured its outstandingconvertible bond. The major part was converted or transferred into anew option bond, running until December 2017 with a staggered coupon.In addition, the remaining convertible bond was extended until July2012 and the coupon ceased for three years.With the capital increase and after consideration of the effects ofthe restructuring of the convertible bond Biofrontera's base capitalwill increase to ? 7,340,068 split into 7,340,068 shares.The funds derived from the capital increase are required to reach theoperative goals of the company and represent an important requirementfor the aspired financial independence of the Biofrontera group.Important mile stones in the process are the market launch of themedical cosmetic Belixos®, foreseen for the fall 2009, and thecompletion of the clinical development of BF-200 ALA for thetreatment of actinic keratosis.Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen, GermanyISIN: DE0006046113, WKN: 604611Contact:Anke zur MühlenBiofrontera AGTel.: +49 (0214) 87 63 222Fax.: +49 (0214) 87 63 290E-mail: a.zurmuehlen(at)biofrontera.com --- End of Message ---Biofrontera AGHemmelrather Weg 201 Leverkusen GermanyWKN: 604611; ISIN: DE0006046113; Listed: Freiverkehr in Börse Berlin, Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart, Open Market (Freiverkehr) in Frankfurter Wertpapierbörse, Regulierter Markt in Börse Düsseldorf;
Datum: 09.09.2009 - 11:34 Uhr
Sprache: Deutsch
News-ID 5632
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 226 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ad hoc: Biofrontera AG: Biofrontera AG successfully places capital increase"
steht unter der journalistisch-redaktionellen Verantwortung von
Biofrontera AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
